|
| ID |
DDInter649 |
| Drug Type |
small molecule |
| Molecular Formula |
C21H16F4N4O2S |
| Molecular Weight |
464.443
|
| Description |
Enzalutamide is an androgen receptor inhibitor used to treat castration-resistant prostate cancer.
|
| ATC Classification |
L02BB04
|
| IUPAC Name |
4-{3-[4-Cyano-3-(Trifluoromethyl)Phenyl]-5,5-Dimethyl-4-Oxo-2-Sulfanylideneimidazolidin-1-Yl}-2-Fluoro-N-Methylbenzamide |
| InChI |
Inchi=1S/C21H16F4N4O2S/C1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/H4-9H,1-3H3,(H,27,30) |
| InChI Key |
WXCXUHSOUPDCQV-UHFFFAOYSA-N |
| Canonical SMILES |
CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F |
| Useful Links |
DrugBank
ChEMBL
PubChem
|